Changes of biochemical parameters in rat intestinal mucosa induced by methotrexate and effects of enteral administration of glutamine

Archive of Oncology

Volumn 12, Issue 1, 2004, Pages 35-38

  Bajin Katić, Katica ^a   Stankov, Karmen ^a   Kovačević, Zoran ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Drug Toxicity; Glutamine; Intestinal Mucosa; Methotrexate; Rats

Indexed keywords

GLUTAMINE; METHOTREXATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL REGENERATION; CONTROLLED STUDY; DOSE RESPONSE; ENTERIC FEEDING; ENZYME ACTIVITY; GASTROINTESTINAL TOXICITY; INTESTINE CELL; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA; NONHUMAN; PARAMETER; RAT;

EID: 4844227308     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0401035B     Document Type: Article

References (21)

1. Rombeau JL. A review of the effects of glutamine-enriched diets on experimentally induced enterocolitis. J Parent Enter Nutr 1990;14:100S-105S.
2. Savovski K, Pujić N, Vranić V, Dimitrijević B. Effects of a modified CMF treatment (cyclophosphamide, methotrexate and 5-fluorouracil) on haematopoietic tissues and Yoshida sarcoma in rats. Acta Oncol 1994;33:793-8.
3. Verburg M, Renes IB, Meijer HP, Taminiau AJM, Buller HA, Einerhand AWC et al. Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats. Am J Physiol Gastrointest Liver Physiol 2000;279:G1037-47.
4. Taminiau JA, Gall GD, Hamilton JR. Response of the rat small-intestine epithelium to methotrexate. Gut 1980;21:486-92.
5. Gwavava NJ, Pinkerton CR, Glasgow JF, Sloan JM, Bridges JM. Small bowel enetrocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood. J Clin Pathol 1981;34:790-5.
6. Kralovanszky J, Prajda N, Kerpel-Frolnus S, Szentirmay Z. Biological model system for investigating gastrointestinal side effects caused by cytostatic agents. In: Mozsik Gy, Hanninen O, Javor T, editors. Gastrointestinal defence mechanisms. London: Pergamon Press; 1981. p. 327-38.
7. Kovačevíć Z, Baj́in-Katić K, Brkljač O. Glutamine-supplemented parenteral and enteral nutrition in catabolic disease states. Arch Oncol 1996;4:17-22.
8. Roth E, Kamer J, Ollenschlager G. Glutamine: An anabolic effector? J Parent Enter Nutr 1990;14:130S-136S.
9. Souba WW, Klimberg VS, Plamley DA. The role of glutamine in maintaining gut structure and function and supporting the metabolic response to injury and infection. J Surg Res 1990;48:383-91.
10. Medina M. Glutamine and cancer. J Nutr 2001;131:2539S-2542S.
11. Kralovanszky J, Prajda N. Biological changes of intestinal epithelial cells induced by cytostatic agents in rats. Arch Toxic 1985;8:94-103.
12. Plummer DT. An introduction to practical biochemistry. 3rd ed. London: McGraw Hill Book Co; 1971. p. 205.
13. Smith RJ, Glutamine metabolism and its physiologic importance. J Parent Enter Nutr 1990;14:40S-44S.
14. Souba WW, Herskowitz K, Salloum RM, Chen MK, Austgen TR. Gut glutamine metabolism. J Parent Enter Nutr 1990;14:45S-50S.
15. Miller AL. Therapeutic considerations of L-glutamine: A review of literature. Alternative Medical Review 1999;4:239-48.
16. Klimberg VS, Nowokedi E, Hutchins L. Glutamine facilitates chemotherapy while reducing toxicity. J Parent Enter Nutr 1992;16:83S-87S.
17. Fox AD, Kripke SA, De Paula J. Effect of glutamine-supplemented enteral diet on methotrexate-induced enterocolitis. J Parent Enter Nutr 1992;12:325-31.
18. Jensen JC, Schaefea R, Nwokeidi E. Prevention of chronic radiation enteropathy by dietary glutamine. Ann Surg Oncol 1994;1 (2):157-63.
19. Decker-Baumann C, Buhl K, Frohmüller S. Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patient with metastatic colorectal cancer. Eur J Cancer 1999;35:202-7.
20. Amores-Sánchez MI, Medina MA. Glutamine as a precursor of glutathione and oxidative stress. Molec Genetics Metabol 1999;67:100-5.
21. Cao Y, Kennedy R, Klimberg S. Glutamine protects against doxorubicin-induced cardiotoxicity. J Surg Res 1999;85:178-82.